5:40 PM · 23 October 2025

US Open: Mixed sentiments on Wall Street 📊IBM loses, Honeywell surges 7%

Key takeaways
US100
Indices
-
-
Honeywell
Stocks
HON.US, Honeywell International Inc
-
-
Key takeaways
  • US100 slips slightly at the U.S. market open
  • Tesla and IBM shares fall after earnings, while Dow Inc. and Honeywell gain.
  • Intel is set to report earnings after the U.S. market close.

Wall Street sentiment was mixed at the opening of the U.S. trading session. As of October 17, about 12% of S&P 500 companies had reported third-quarter results. An impressive 86% of them delivered earnings per share (EPS) above analysts’ expectations — a rate higher than the five-year average of 78% and the ten-year average of 75%. However, the average earnings surprise was 5.9%, below the five-year average of 8.4%.The overall earnings growth rate (as of October 17), which includes both reported results and estimates for companies yet to report, currently stands at 8.5%, compared with 7.7% last week and 7.9% at the end of September, according to FactSet Research Systems data. The US100 index is struggling to hold above the 25,000-point level. In the medium term, the benchmark may move back toward testing the 50-day exponential moving average (EMA50, orange line), especially if bulls fail to push it decisively above this psychologically important barrier. Today, after the US session, Intel (INTC.US) will report earnings.

Source: xStation5

Tesla opened the session with a nearly 3% downside gap.

Source: xStation5

Industrial giant Honeywell benefited from a strong quarterly report, with its shares returning above the 200-day exponential moving average (EMA200, red line), attempting to reverse a medium-term downtrend.

Source: xStation5

Company News

  • Tesla (TSLA.US) fell 3.5% after profits plunged despite a record number of vehicle sales.

  • Dow Inc. (DOW.US) rose 6% after the U.S. chemical company beat third-quarter operating EBITDA estimates.

  • Honeywell (HON.US) gained 4% following better-than-expected adjusted earnings per share (EPS).

  • IBM (IBM.US) declined 7% as revenue in key software segments — including the Red Hat unit — fell short of expectations.

  • Las Vegas Sands (LVS.US) advanced 5% after reporting third-quarter EPS above analyst forecasts.

  • LendingClub (LC.US) jumped 11% after providing upbeat Q4 loan origination guidance; JPMorgan upgraded the stock to overweight.

  • Moderna (MRNA.US) dropped 4% after its cytomegalovirus vaccine failed to meet its endpoint in a late-stage trial.

  • Molina Healthcare (MOH.US) plunged 18% after cutting full-year adjusted profit guidance due to higher medical costs across all business segments.

  • T-Mobile US (TMUS.US) slipped 1% following its third-quarter results.

  • Tractor Supply (TSCO.US) fell 3% after narrowing its full-year sales forecast, with the midpoint near the lower end of the previous range.

  • Ribbon Communications (RBBN.US) sank 14% after disappointing Q3 profit and weak Q4 revenue guidance.

  • Ventyx Biosciences (VTYX.US) soared 105% after mid-stage clinical trial results showed significant reductions in cardiovascular risk factors among obese patients.

Nvidia in Consolidation

U.S. stock indices have entered a consolidation phase, perfectly mirrored by Nvidia’s share price, which is currently trading around the 50-day exponential moving average (EMA50, orange line).

Source: xStation5

23 October 2025, 9:19 PM

STMicroelectronics shares down 14% amid mixed future outlook📉

23 October 2025, 7:23 PM

US100 gains 0.5% 📈Kansas City Fed Index above estimates

23 October 2025, 7:12 PM

NATGAS loses after the EIA inventories report

23 October 2025, 7:05 PM

Stock of the Week - Merck & Co Inc (23.10.2025)

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer are risky. XTB is regulated by the DFSA.